Precision Medicine Approaches to Lung Adenocarcinoma With Concomitant MET and HER2 Amplification
BMC Cancer - United Kingdom
doi 10.1186/s12885-017-3525-9
Full Text
Open PDFAbstract
Available in full text
Date
August 10, 2017
Authors
Publisher
Springer Science and Business Media LLC